4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-21-023433
EVP, Corp Strategy & Develop sold 3,700 shares at an average $402.21 ($1,488,175)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-08-06 | Sale | −1,458 | $400.91 | $584,522 | 10,704 | D: show line 1 in the form |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-08-06 | Sale | −900 | $401.66 | $361,498 | 9,804 | D: show line 2 in the form |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-08-06 | Sale | −1,042 | $402.43 | $419,335 | 8,762 | D: show line 3 in the form |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-08-06 | Sale | −300 | $409.40 | $122,820 | 8,462 | D: show line 4 in the form |
| Open-market sales · 3,700 sh · avg $402.21 · $1,488,175 | |||||||
Loading xslF345X03/form4.xml…